In the Cp network (bottom panel), AKR1B1 (member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins) showed interaction with many drugs, likewise FGFR3 (member of the fibroblast growth factor receptor family) emerged to be second reactive protein interacting with other cancer treatment drugs. The gene discussed is AKR1B1; the disease is cancer.